Innocare Pharma LtdEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 13.49 HKD | 20,62 HKD | 9,65 HKD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - HKD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.493.798.235 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Innocare Pharma Ltd
Mitarbeiter 1.176
Handelsplatz HK
Ticker Symbol 9969
IPO Datum -
Adresse Building 8, Beijing, China, 102206
Webseite https://www.innocarepharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Jisong Cui Ph.D. | Co-Founder, Chairwoman & CEO |
| 2 | Dr. Renbin Zhao Ph.D. | Senior VP of Clinical Development & Medical Research and Executive Director |
| 3 | Mr. Xin Fu | Chief Financial Officer |
| 4 | Mr. Nan Gao | Chief Operating Officer |
| 5 | Yue Tan | Accounting Supervisor |
| 6 | Dr. Xiangyang Chen Ph.D. | Chief Technology Officer |
| 7 | Ms. Bei Yuan | Joint Company Secretary & Senior Director of Investor elations |
| 8 | Ms. Junsu Wang | General Counsel |
| 9 | Mr. Davy Ouyang Ph.D. | VP & Head of Biology |
| 10 | Mr. Jeff Chen | Chief Commercial Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.